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Co-assembly of Fmoc-based self-assembling peptides results in the formation of 
homogenous nanofibres for high-density, concomitant peptide presentation. 
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Abstract 
As novel biomaterials for tissue engineering, the hydrogels formed by self-assembling 
peptides (SAPs) enable the development of finely tuned cellular microenvironments suitable 
for a range of biomedical applications. Recently, the development of bioactive minimalist 
fluorenylmethyloxycarbonyl (Fmoc) peptide sequences has opened the possibility to provide 
both physical and biochemical cues for directed cell growth with minimal synthesis. 
However, due to a lack of understanding in the process and for ease of analysis, these 
systems typically consist of a single SAP, which results in chemically and biologically 
homogenous scaffolds. In order to improve the utility of these systems, significant 
opportunities lie in the controlled inclusion of several biological motifs via the co-assembly 
of multiple SAPs into a single structure. This potentially enables the concomitant 
presentation of multiple bioactive motifs in a single material, resulting in a sophisticated 
biomimetic scaffold. Here, we consider the incorporation of multiple Fmoc-SAPs into a 
single hydrogel scaffold through a) co-assembly and b) hydrogel-mixing. Two important 
extracellular matrix (ECM) protein-derived peptides: arginine-glycine-aspartate (RGD) and 
isoleucine-lysine-valine-alanine-valine (IKVAV) were included in minimalist Fmoc-SAPs 
and used to form co-assembled and hydrogel-mixed systems. Both systems were assessed in 
terms of their molecular arrangement, (nano)structure, and the mechanical properties of the 
hydrogel. Our results indicate that both approaches were successful, forming stable 
nanofibrous networks and hydrogels. Importantly, our results demonstrate that mixed gels 
formed a hydrogel consisting of a mixture of two homogeneous structures, whereas co-
assembly facilitated a single randomly sorted nanofibrous assembly. This research 
demonstrates a facile method to functionalise this class of hydrogel, and provides a basis for 
future in vitro and in vivo studies of these systems for tissue engineering to assess the effects 
of the distribution and presentation of multiple signals. 
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The successful application of biomaterials in tissue engineering requires materials that have 
carefully tuned physical and chemical properties on biologically relevant scales to promote 
cellular regeneration while exhibiting little or no immune response.[1, 2] In addition to being 
both biocompatible and non-cytotoxic after degradation, such materials must provide three-
dimensional (3D) nanostructural support for cells as well as biochemical cues to promote and 
regulate cell behaviour such as cell adhesion, migration, proliferation and differentiation.[1, 3, 
4] These requirements present significant challenges in the design of tissue engineering 
materials, placing constraints on the types of materials that can be used and how their 
structures can be applied to cell regeneration and repair.  
Nanostructured 3D matrix scaffolds are some of the most promising and important 
biomaterials that have been applied to tissue engineering.[2, 5] Developing design rules for 
these materials allow them to be purpose-built to provide a suitable cellular 
microenvironment that mimics the native ECM.[1-3, 6] A variety of scaffolds have been 
investigated including electrospun nanofibres,[7-9] biologically derived and synthetic hydrogel 
scaffolds,[10-16] and SAP hydrogels.[2, 17, 18] 
SAP hydrogel scaffolds have proven to be particularly promising due to their inherent 
biocompatibility, tuneable mechanical and chemical properties, ability to fill irregularly 
shaped voids, and their porous, nanofibrous structure, making them ideal candidates for 
applications in regenerative medicine.[2, 19] They are a novel class of biomimetic materials 
containing a short sequence of amino acids (peptide).[20, 21]  
Recently, the potential of minimalist SAP systems for biomedical applications has gained 
much interest, due to their short length and ability to present biochemical cues at high 
densities.[17, 19, 22] Underpinning the structural formation of one group of these systems, 
fluorenylmethyloxycarbonyl (Fmoc) SAPs, is π-β assembly.[22, 23] Here, under appropriate 
conditions, the Fmoc groups stack on top of each other through π-π stacking forming the 
backbone of the Fmoc-SAP structure, and the pendant peptides align through hydrogen 
bonding to form a network of anti-parallel β-sheets.[24] These assemblies subsequently close 
to form nanotubes with the peptide sequence exposed at high density on the surface.[22] 
Individual nanotubes then align longitudinally, resulting in the formation of nanofibre 
bundles that constitute the hydrogel scaffold.[19] The minimalist nature of Fmoc-SAP systems 
is advantageous over traditional SAP systems as they are relatively inexpensive and quick to 
produce.[19, 23] In addition, the Fmoc moiety itself has been shown to possess anti-
inflammatory properties, a valuable property for the development of adjuvant scaffolds in 
cellular applications.[25]  
Another promising advantage of Fmoc-based SAP systems over other, longer SAP systems is 
their heightened potential for biofunctionalisation. Previously, biofunctionalisation of non-
Fmoc peptides (such as RADA16) and peptide amphiphiles (PA), achieved through capping 
with short bioactive sequences, has shown some promise in eliciting an improved cellular 
response in vitro and in vivo.[17, 26-28] The capping of PAs with IKVAV in particular has seen 
selective promotion of cell differentiation, neurite extension, and neural differentiation, as 
well as reduced development of astrocytes (an inflammatory cell within the central nervous 
system (CNS)), indicating the formation of an appropriate cellular microenvironment for 
tissue engineering, in this case within the CNS.[17, 29-31] While these results are promising, the 
relative size of the bioactive epitope to the PAs results in an inherently low-density 
presentation of the epitope.[19, 31, 32] In addition, work on biofunctionalised PAs has shown 
that density, rather than dimensionality, of the biofunctional epitope presentation plays a 
more important role in cell differentiation and is likely to play a wider role in the 
biofunctionality of the introduced material.[26] 
Our previous research has focused on the high-density presentation of RGD and IKVAV 
epitopes (Figure 1a & b).[19, 33, 34] The laminin-derived IKVAV and the fibronectin-derived 
RGD sequences are common components of the mammalian ECM.[19, 35] These Fmoc 
peptides have been rationally designed to form SAP hydrogels at physiological pH,[19] 
allowing for control of various cellular processes including survival, adhesion, 
differentiation, migration and proliferation.[2] Incorporation of these sequences has enabled us 
to develop an Fmoc-SAP scaffold that more closely mimics the ECM, both physically and 
chemically. However, while biofunctionalisation of SAP scaffolds represents a significant 
advancement in the development of cell scaffold materials, cellular control is somewhat 
limited in this instance by the presentation of a single biochemical cue. 
 Figure 1. (a) Structural formulae for the bioactive Fmoc-SAP sequences, (a) Fmoc-FRGDF, 
(b) Fmoc-DIKVAV with (a’ & b’) corresponding TEM images (scale = 200 nm). (c) π-β Co-
assembly process where peptides are mixed prior to gelation and co-assembled via a pH 
switch method. (d) In contrast, the mixed assembly process results from the mixing of two 
previously prepared gels, giving rise to an inhomogeneous hydrogel. 
 
The combination of multiple signals in a single, homogenous scaffold presents the potential 
for a synergistic effect on cellular response through the improved spatial and chemical 
arrangement of multiple bioactive signals.[36] A range of co-assembled systems has been 
reported,[37, 38] however, bioactive co-assembly has only previously been investigated in PA 
systems, with limited success,[36] and in an Fmoc-SAP system where a non-gelating Fmoc-
RGD molecule was used to decorate fibrils of Fmoc-FF.[39] In each case, the mechanism by 
which the SAPs molecularly pack into the fibres is not well understood.  
Here, we present a first step towards the development of truly co-assembled minimalist 
bioactive Fmoc-SAP scaffolds for the high-density presentation of multiple biochemical cues. 
In order to confirm the successful formation of co-assembled structures, we characterised the 
assembly process across all length scales; the molecular packing using Fourier transform 
infrared spectroscopy (FTIR), circular dichroism (CD) spectroscopy, and SAXS; the 
structures at longer length scales by transmission electron microscopy (TEM); and the bulk 
mechanical properties of the hydrogels by rheological measurements. We considered various 
co-assembled combinations of our two individual Fmoc-SAPs (Fmoc-FRGDF and Fmoc-
DIKVAV) and distinguished the resulting co-assembled hydrogel structures (Figure 1c) from 
both single Fmoc-SAP and parallel mixed Fmoc-SAP systems (Figure 1d) to show that a 
unique homogenous nanofibrous hydrogel was obtained.  
 
Results and Discussion 
Self-Assembly of the Systems under Physiological Conditions  
Titration of the single and co-assembled Fmoc-SAP systems (Figure 2a) was employed to 
determine the pKa of the dual peptide system as a predictor of gelation behaviour. The pH 
switch-triggered self-assembly of these Fmoc-SAPs is correlated to the pKa of the peptide, 
which is dependent on the composition of the peptide chain.[19] The titration curves for the 
single and co-assembled Fmoc-SAP systems displayed multiple pKa shifts (inflection points 
on the curves in as seen in Figure 2a), corresponding to the formation of intermediary 
structures, with solution-gelation transition occurring at a pH in this region, when nanofibres 
predominate the system. In each case, significant pKa shifts were observed between pH 7 and 
pH 9, indicating the ability of each system to form a stable hydrogel at physiological pH (~ 
7.4), as was experimentally confirmed.[19] These results indicate the flexibility of the gelation 
pH when tailoring a given system. Interestingly, the titration curve for the co-assembled 
FRGDF-DIKVAV appears as an average of the titration curves of the constituent single 
SAPs, Fmoc-FRGDF and Fmoc-DIKVAV, indicating a potential mechanism through which 
the gelation behaviour of co-assembled Fmoc-SAP systems can be tailored (Figure 2a). 
Overall, these titration curves demonstrate the pH neutrality of each Fmoc-SAP hydrogel, 
indicating the potential for these materials to be used for in vitro and in vivo applications. 
 
Figure 2. (a) Titration curves showing shifts in pKa for the individual peptides and FRGDF-
DIKVAV combination. TEM images of (b) mixed and (c) co-assembled SAP hydrogels 
confirming nanofibre formation (scale = 200 nm). 
 
 
Stable Nanofibrous Networks Retained Across Co-Assembled SAP Systems  
Confident that self-assembly was occurring under physiological pH, the formation of the 
nanofibrous structures and the bundling of the networks for the mixed and co-assembled 
FRGDF-DIKVAV system was confirmed with negatively stained TEM (Figure 2b & c). As 
expected, the Fmoc-SAPs yielded nanofibres with consistent morphology and diameters, 
suggesting that the overall mechanism of nanofibre assembly was broadly maintained. The 
characteristic nanoscale assemblies observed for each of the single Fmoc-SAP systems were 
also prominent in the TEM micrographs of the mixed and co-assembled systems. Across both 
combined Fmoc-SAP systems, a stable nanofibrous network was maintained, with similar 
nanofibre dimensions observed in each case (Figure 2b & c). 
The existence of comparable stable networks demonstrates the non-destructive nature of the 
hydrogel-mixing (Figure 2b) and that co-assembly resulted in nanoscale morphologies 
similar to the individual assemblies (Figure 2c), rather than allowing a secondary type of 
structure to form.[40] However, while the nanoscale assemblies in each system resulted in the 
formation of nanofibres, morphological differences were observed between the hydrogel-
mixed and co-assembled FRGDF-DIKVAV systems, suggesting that the combination method 
also plays a role in determining the overall network structure. Although drying effects must 
be considered, co-assembled FRGDF-DIKVAV displayed a lesser degree of nanofibre 
bundling than its mixed counterpart, with larger nanofibres distributed throughout the system. 
The co-assembled system contains nanofibres with width dimensions of 14.6 nm ± 1.9 nm 
(mean ± standard deviation)(Figure 2b), which is statistically significantly different (p = 
0.0034) from the mixed system nanofibres of 10.9 nm ± 1.9 nm (Figure 2c). Furthermore, the 
greater standard deviation of the nanofibre widths in the mixed system (relative to the mean 
width) suggests inhomogeneity in the system. 
 
Mechanical Properties of Hydrogels 
For successful in vivo applications as adjuvant cell scaffolds, it is essential that the hydrogel 
scaffold closely mimics the native ECM both in terms of the chemical signal presented and 
the physical support provided.[31] The elastic moduli of neural tissue ranges from 102 - 103 Pa 
while the moduli for connective and muscle tissues are ~ 104 Pa.[41] As such, Fmoc-SAP 
hydrogels with elastic moduli in these ranges have the potential to act as adjuvant ECM-
mimetic cell scaffolds with appropriate properties for tissue engineering applications.[42] 
Therefore, it is important to determine the rheological properties of co-assembled Fmoc-SAP 
hydrogels. The rheological properties of hydrogels are controlled by a number of parameters, 
including nanofibre stiffness, concentration, branching and number/type of entanglements.[43]  
Figure 3 shows the storage moduli (G’) and loss moduli (G”) of the single, mixed, and co-
assembled Fmoc-SAP systems as a function of applied frequency (Hz). All hydrogels 
displayed viscoelastic gel behaviour; with the storage moduli values higher than the loss 
moduli values with the range of frequencies measured.  
 Figure 3. Rheological data for single Fmoc-SAP sequences (a) FRGDF, (b) DIKVAV with 
comparison to  (c) mixed and (d) co-assembled systems (G’ = closed circles; G” = open 
circles). 
For the single Fmoc-SAP systems, the G’ value of Fmoc-DIKVAV was at ~104 Pa (Figure 
3b), in the appropriate range for application to tissue engineering, while the moduli for Fmoc-
FRGDF are much lower (Figure 3a), as previously reported.[19, 42] The G’ value of the mixed 
FRGDF-DIKVAV system (Figure 3c) was similar to that of single Fmoc-DIKVAV, whereas 
the ratio of G”/G’ (the tan δ value) was similar to that of the single Fmoc-FRGDF system at 
0.1-0.13 between 0.1-1 Hz. This suggests that the two Fmoc-SAPs co-existed as two separate 
non-interactive networks and both contributed to the overall rheological properties of the 
mixed system. In contrast, the moduli for co-assembled FRGDF-DIKVAV showed a ~20% 
reduction relative to Fmoc-DIKVAV, but the tan δ was maintained (Figure 3d). This suggests 
that co-assembled FRGDF-DIKVAV is a cooperative system with modification to the fibril 
interaction, which influenced the type/number of entanglements formed. Importantly, the 
rheological properties for co-assembled FRGDF-DIKVAV represent an intermediate between 
the weakest gel, Fmoc-FRGDF on one end and the strongest Fmoc-DIKVAV hydrogel on the 
other. This range of material properties suggests an as yet unidentified opportunity for 
controlling the stiffness of Fmoc-SAP hydrogels, where the combination of Fmoc-SAPs in 
particular ratios could achieve the tuning required for select tissue engineering applications. 
 
Spectroscopic Analysis of Molecular Packing  
In order to determine whether π-β assembly was the dominant structural mechanism driving 
the co-assembly of the Fmoc-SAP hydrogel systems spectroscopic analysis of bulk molecular 
interactions with both FTIR and CD were used. SAXS was then used to determine any 
differences between the structures of mixed and co-assembled systems on a fibrillar level.  
FTIR spectra of each of the single, mixed, and co-assembled SAP systems are shown in 
Figure 4a. In each case, a major peak at approximately 1630 cm-1 and a minor peak at 
approximately 1690 cm-1, indicating the presence of anti-parallel β-sheets, typical of this 
class of assembly.[22] CD spectra for the single and mixed SAP systems similarly indicate the 
presence of β-sheets, with local maximum bands at approximately 190 nm and/or local 
minimum bands at approximately 218 nm (Figure 4b).[44] However, the CD spectrum for the 
co-assembled system is inverted, a result of the π-π* Cotton effect from the Fmoc moiety, 
implying an opposite chirality of the co-assembled system.[45, 46] In addition, broad transitions 
in the 230 – 270 nm region for each of the systems (arising from numerous π-π* transitions) 
indicate the supramolecular alignment of the peptide nanofibres into a hydrogel scaffold.[19] 
The large transitions for the single Fmoc-FRGDF and Fmoc-DIKVAV hydrogels in this 
region indicate a high degree of fibre bundling.[33] The same effect is observed for the mixed 
and co-assembled SAP systems, though co-assembled FRGDF-DIKVAV displays smaller 
transitions relative to both the single and mixed SAP systems. This could be due to a reduced 
number of fibrils present due to a single population of heterogeneous structures. 
 
Figure 4. (a) FTIR and (b) CD spectra for single, mixed, and co-assembled SAP hydrogels. 
The transitions present in the region 180-220nm of the CD spectra for the single and mixed 
systems indicate the presence of β-sheets, On the other hand, the co-assembled FRGDF-
DIKVAV system displayed a unique CD spectrum in this region, demonstrating an 
absorption shift of the minima from ~218 to 205nm, and a greatly reduced maxima ~190nm, 
an effect possibly arising from the novel interaction of aromatic and the carboxyl groups 
induced during the heterogeneous molecular packing of the penta- and hexapeptides[47].   
 
Structural Determination of SAP Assemblies using SAXS 
Previous SAXS investigation of β-peptide oligomers indicated a good fit to a form factor 
model of a hollow cylinder with polydisperse radius to solutions of the β-peptide oligomers, 
suggesting that simple cylindrical models can provide suitable fits for β-peptide solutions.[48] 
To determine the most suitable form factor model for our systems, different models were 
fitted to the experimental SAXS data, using fitting algorithms included in the NIST IgorPro 
software (Figure 5). 
 
Figure 5. (a) Scattering data obtained using SAXS for FRGDF (blue) showing various 
cylindrical models fitted to data including cylinder (green), cylinder with polydisperse radius 
(purple), hollow cylinder (black), flexible cylinder (orange) and hollow cylinder with 
polydisperse radius (red). The hollow cylinder with polydisperse radius is the best fit for our 
SAXS data as highlighted in (b) at higher Q values for FRGDF. Similar fits were obtained 
using this model for (c) DIKVAV, (d) mixed and (e) co-assembled hydrogel systems (blue = 
SAXS experimental data; red = hollow cylinder with polydisperse radius model). For all 
cylindrical model fits for DIKVAV, DIKVAV/FRGDF mixed and co-assembled systems see 
Supplementary Figure 2. 
TEM images were used to guide initial parameter values for the cylinder diameter and length, 
while the scattering length densities were adjusted to account for the use of these models for 
SAXS data (as the models were developed for small angle neutron scattering (SANS) 
experiments).[49] In each case, the optimal fit was achieved using the hollow cylinder with 
polydisperse radius form factor model (Figure 5). This result aligns with the previously 
observed model fitting for β-peptide oligomer solutions.[48, 50] However, in our case, high 
quality fits were obtained without the need for associated structure factors. 
Table 1. Hollow cylinder with polydisperse radius form factor model parameters for different peptide 
systems 
Parameter FRGDF DIKVAV Mixed FRGDF-DIKVAV 
Co-Assembled 
FRGDF-DIKVAV 
Length (Å) 3015 2979 2900 3315 
Mean Core 
Radius (Å) 24.25 20.65 23.40 29.71 
Radial Shell 
Thickness (Å) 29.52 28.17 27.06 51.88 
Radial Polydispersity 0.06 0.10 0.19 0.12 
SLD Core (Å-2) 1.31 x 10-5 1.33 x 10-5 1.36 x 10-5 1.28 x 10-5 
SLD Shell (Å-2) 9.94 x 10-6 9.91 x 10-6 9.94 x 10-6 9.76 x 10-6 
SLD Solvent (Å-2) 9.52 x 10-6 9.49 x 10-6 9.54 x 10-6 9.49 x 10-6 
Chi-Squared (χ2) *4.40 1.62 1.88 1.02 
*Though the χ2 value here is high, this fit showed the best χ2 value for FRGDF (see Supplementary Table 1) 
The theoretical form factor model fit to the experimental data for each of the peptide systems 
enables physical properties of the peptide nanofibres to be determined (Table 1). In the single 
and mixed systems, the peptide nanofibres exhibit similar core and shell thicknesses of 
around 20-25 Å, and similar lengths, on the order of 3000 Å. However, for the co-assembled 
system, the mean core radius was increased to 29.7 Å and the radial shell thickness to 51.9 Å, 
closely agreeing with the nanofibre diameters observed in the TEM images (Figures 2b and 
2c). These radial parameters (an increase in radial shell thickness of greater than 75% relative 
to the other peptide systems) are likely a result of the interaction of the two differently shaped 
and charged peptide sequences, requiring an increase in the radial shell thickness in order to 
achieve packing stability. Importantly, this suggests that the two SAPs are incorporated into a 
single structure, rather than forming a self-sorted heterogeneous system that would 
demonstrate properties closer to those of the mixed hydrogel. This result supports the 
rheological measurements, where the co-assembled system was much weaker than the mixed 
or the Fmoc-DIKVAV systems, but stronger than the Fmoc-FRGDF, suggesting a distinct 
structure composed of the co-operative individual Fmoc-SAPs (Figure 3). The increase in 
nanofibre width highlights the potential for co-assembly to permit greater control over fibril 
morphology, which has not been previously attained in other SAP systems. Through altering 
the relative ratios of the different SAPs present in the co-assembled system, we can 
potentially alter the nanofibre width, allowing us to selectively tune fibril morphology for 
tissue-specific ECMs. The polydispersity in the cylinder (nanofibre) radius provides further 
confirmation of the formation of homogenous structures, with polydispersity values ranging 
between 0.06 and 0.12 for the single and co-assembled systems, indicating minimal variation 
in the cylinder radius along its length. However, as expected for the mixed system, the 
polydispersity value increases to 0.19, suggesting a greater degree of inhomogeneity arising 
from the presence of two separate populations of fibrils. It is also interesting to note that each 
of the peptide systems also displays higher scattering length density (SLD) values for the 
cylinder core than for either the cylinder itself, or the solvent, an effect that could be due to 
the absorption of salt from the PBS solution into the centre of the nanofibre cylinder.  
This data underlies the importance of deeper analysis of two-component systems. In terms of 
the bulk properties, both the mixed and co-assembled systems appear quite similar to the 
individual FRGDF and DIKVAV systems, as is expected. Despite this, the SAXS results 
demonstrate clear differences in the structure of the co-assembled system highlighting its 
usefulness as a technique for analysing multicomponent systems. 
 
 
 
Conclusions 
In summary, novel co-assembled Fmoc-SAP systems were developed with the potential to 
present multiple bioactive epitopes and synergistically provide appropriate physical and 
chemical cues for cellular regeneration and repair. We demonstrate that multiple signals can 
be included into a nanofibrillar SAP hydrogel by mixing two preformed gels, or by co-
assembling two distinct SAPs. In particular, we show for the first time the successful co-
assembly of multiple bioactive SAP sequences into a single homogeneous nanofiber scaffold. 
This process enables us to produce a tuneable biomaterial that can include multiple bioactive 
sequences in precise ratios. Importantly, the observed increase in the width of the co-
assembled nanofibres demonstrates a potential avenue for the tuning of fibril morphology 
through the co-assembly of multiple SAP systems, indicating the capacity for co-assembly to 
enable tuning of biomimetic SAP scaffolds to the ECM of particular tissues. This study 
describes the potential for a single nanofibrous system to concomitantly present these signals 
to individual cells, providing a suitable ECM-mimetic material for the complex coordination 
of cell fate. This co-assembled system therefore provides a platform for an enhanced 
biomimetic material for future in vitro and in vivo tissue engineering applications.  
 
Methods 
Solid Phase Peptide Synthesis (SPPS): Fmoc-SAPs were made using solid phase peptide 
synthesis (SPPS)[51] in a custom rotating glass reactor vessel at a 0.4 mmol scale. Fmoc 
protected amino acids, Hydroxybenzotriazole (HOBt), O-Benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU) and Wang based resins were purchased 
from GL Biochem (China). All other chemicals were purchased from Sigma-Aldrich. 
Dimethylformamide (DMF) was dried for a minimum of 2 hours prior to use with 4 Å 
molecular sieves. 
Peptide synthesis was achieved by the stepwise deprotection of the N-terminal Fmoc group of 
the resin anchored amino acid using a solution of 20% piperidine in DMF for 20 minutes, 
followed by a coupling step using a solution of the next Fmoc-amino acid in 2.0 mmol 
HoBT, 1.9 mmol HBTU and 4.8 mmol N,N-diisopropylethylamine (DIPEA) in DMF for 60 
minutes. This process of deprotection and coupling was repeated until the desired peptide 
was synthesised. The final Fmoc group was not removed. Deprotection and coupling of 
amino acids was verified using a Kaiser test for the detection of free amines.[51] Once SPPS 
of the desired sequence was complete, the Fmoc protected peptide and resin was washed with 
ethanol and left to dry under constant vacuum for 2 days. Once complete, a cleavage solution 
of trifluororoacetic acid (TFA), 2.5% deionised water (DI H2O) and 2.5% triethylsilane 
(TES) was prepared. The resin was left to stand in the cleavage solution for 2 hours. 
Following cleavage, the peptide solution was filtered through glass wool. Excess TFA was 
then evaporated using nitrogen until approximately 5 mL of peptide solution was left. The 
peptide solution was then precipitated, followed by 5 washes in cold ether before being 
collected and allowed to dry under constant vacuum for 2 days. The peptide was then ground 
into a fine powder before being placed under constant vacuum for a further 7 days.  
Single Fmoc-SAP Hydrogel Preparation: Peptide hydrogels were prepared at concentrations 
of 10 and 20 mg/mL. Prior to peptide preparation, 10 mL of phosphate buffered saline (PBS) 
solution was prepared and the pH noted. For peptide preparation, 5 mg of peptide was 
weighed and placed in an eppendorf vial. 50 µL of deionised water (DI H2O) was added 
dropwise to the vial while the solution was vortexed. Next, 25 µL of 0.5 M sodium hydroxide 
(NaOH) was similarly added dropwise, and if necessary sonication of the solution was 
performed using an Eumax UD80SH-2L ultrasonic cleaner at room temperature for periods 
of between 2 and 3 minutes until full dissolution of the peptide. Gelation was achieved via 
the dropwise addition of 0.1 M hydrochloric acid (HCl) over vortex. As this process 
continued, the hydrogel pH was measured using an Oaktron pH 700 micro pH electrode 
(Thermo Scientific) until a stable hydrogel at pH slightly above the PBS pH was reached. 
Finally, PBS was added dropwise to yield a total solution of 500 µL for a concentration of 10 
mg/mL or until a total solution of 250 µL for a concentration of 20 mg/mL. Mass 
spectrometry was performed to confirm the desired peptide sequence was synthesised 
(Supplementary Figure 1). 
Mixed Fmoc-SAP Hydrogel Preparation: The mixed Fmoc-SAP hydrogel consisted of two 
different single Fmoc-SAP hydrogels, Fmoc-FRGDF and Fmoc-DIKVAV. In each case, the 
single Fmoc-SAP hydrogels were prepared as detailed above. The mixed Fmoc-SAP 
hydrogel was then prepared through the combination of the single Fmoc-SAP hydrogels over 
vortex. Single Fmoc-SAP hydrogels were combined in volumetrically equal ratios, with 
vortex mixing used to combine the single Fmoc-SAP hydrogels. 
Co-Assembled Fmoc- SAP Hydrogel Preparation: The co-assembled Fmoc-SAP hydrogel 
was prepared in a similar manner to the single Fmoc-SAP hydrogels, however the single 
peptide used in hydrogel preparation was replaced with two different peptides, Fmoc-FRGDF 
and Fmoc-DIKVAV. These peptides were combined in equal mass ratios to a total mass of 5 
mg. Hydrogel formation was then achieved as detailed in section above. 
Transmission Electron Microscopy: Negative stain TEM was performed using a 125 kV 
Hitachi H7100FA electron microscope with a LaB6 cathode. Formvar coated copper grids 
were prepared and electron glow-discharged for 30 seconds at 15 mA. A piece of parafilm 
was prepared with a 20 µL drop of hydrogel sample (prepared as above), two 20 µL drops of 
DI H2O and two drops of uranyl formate (UF) solution (0.75%). The Formvar-coated side of 
the grid was applied to the hydrogel sample for 30 seconds before excess was blotted off 
using filter paper. The same technique was used for each drop of water (3 seconds each) and 
each drop of UF (3 seconds followed by 20 seconds)[52]. Any excess stain solution was 
blotted off and the grid was allowed to dry overnight before imaging in the TEM. Nanofibre 
dimensions for the mixed and co-assembled systems were calculated based on the TEM 
images using ImageJ. A selection of 10 width measurements across different nanofibres were 
taken and a two-tailed T-test used to compare the mean width values between co-assembled 
and mixed systems. 
Titration: 50 µL of 1 M NaOH was added dropwise to a vial containing 10 mg of peptide 
while mixed over vortex. Next, 200 µL of DI H2O was similarly added dropwise over vortex. 
The pH of the solution was measured using an Oaktron pH 700 micro pH electrode (Thermo 
Scientific). 10 µL of 0.2 M HCl was added dropwise over vortex until the hydrogel solution 
reached pH 3. pH was measured after addition of each 10 µL of HCl. 
Rheology: Rheological analysis was performed using a Kinexus Pro+ Rheometer (Malvern). 
Approximately 0.5 mL of hydrogel sample was placed on a flat plate geometry with solvent 
trap (Upper Geometry: PU20 SR1351 SS, Lower Geometry: PLS55 C0177 SS). A gap 
distance of 0.2 mm was used and multiple frequency sweeps were performed for frequencies 
ranging from 0.1–100 Hz with a 0.1% strain at a constant temperature of 25°C. 
Fourier Transform Infrared Spectroscopy: FTIR was completed using an Alpha Platinum 
ATR FTIR (Bruker Optics). Approximately 100 µL of peptide hydrogel was placed on the 
single reflection diamond and the pressure applicator used to adequately spread hydrogel 
over crystal surface. Absorbance scans of the amide I region (1550 to 1750 cm-1) were 
obtained for each peptide, and a background buffer scan subtracted. 
Circular Dichroism: CD was completed using a Chirascan CD Spectrometer (Applied 
Photophysics Limited). 1000 µL of peptide hydrogel solutions were prepared in 1:200 ratios 
with DI H2O. Using a 400 µL cuvette with a 10 mm pathlength, a baseline scan of DI H2O 
was completed and subtracted from the following peptide CD scans. The cuvette was filled 
with 400 µL of peptide solution and a CD scan from 180 nm to 320 nm with a step size of 0.5 
and 1 nm bandwidth was obtained. The resulting data was averaged and smoothed post-
acquisition using software provided by Chirascan prior to analysis. 
Small Angle X-Ray Scattering: SAXS was performed using the SAXS/WAXS beamline at 
the Australian Synchrotron. Measurements were taken using two different camera lengths: 
900 mm and 7000 mm with an X-ray wavelength of 1.0332 Å. These camera lengths enabled 
the scattering vector (q) to be measured across the range 0.008 to 0.7 Å-1. The diffraction 
pattern was recorded on a Pilatus 1M detector (170 mm x 170 mm, effective pixel size of 172 
μ x 172 μm), and processed using the Australian Synchrotron ScatterBrain software. 
Hydrogel samples were prepared, as detailed above, two days prior to testing and stored in 
eppendorf vials. Prior to sample exposure, PBS backgrounds were loaded into 1.5 mm glass 
capillaries and sealed to prevent evaporation. Capillaries were then loaded into a custom 
mount designed to enable movement of the capillaries in two dimensions. Two 5-second 
exposures were taken for each sample background using the two different camera lengths. 
PBS backgrounds were then removed from the capillaries and replaced with hydrogel 
samples. Capillaries were then resealed and remounted for measurement. Multiple 5-second 
exposures were taken for each sample on the two different camera lengths at different 
positions along the capillary length.  
Repeated measurements for each sample on each camera length were averaged and the PBS 
background subtracted using ScatterBrain. q calibration was performed using air shot 
scattering curves, though the use of capillaries prevented standard intensity normalisation. To 
circumvent this issue, intensity normalisation was performed relative to a known scattering 
curve for de-fatted human serum albumin (DFHSA) at a protein concentration of 1 mg/mL. 
Due to weak scattering at higher q values, the background was scaled by 0.9 prior to 
subtraction from the sample scattering data. Data for each sample on the two different camera 
lengths were then combined using IgorPro, though data at the lower q range (obtained using 
the 7000 mm camera length) showed a linear scattering curve for all samples (likely due to 
aggregation) and so was discarded. Analysis of the scattering curves for each sample was 
performed across the q range 0.01 to 0.3 Å-1. The intensity of the x-rays scattered from each 
sample, I(q), was then compared to a number of theoretical form factors, F(q), which result 
from the particle geometry. I(q) can be described as the product of the number density of 
scattered objects (np), the form factor (F(q)), and the structure factor (S(q) = 1, for our dilute 
system), which describes interparticle interactions (Eq. 1). 
   (1) 
I(q) for each of our samples was compared to form factor models provided by the National 
Institutes of Standards and Technology (NIST) for use in conjunction with IgorPro, with the 
quality of the fit estimated using a chi-square test.[49] These models included calculations of 
np, though structure factors had to be calculated separately. While structure factors are widely 
used to generate higher quality models of x-ray scattering intensity, IgorPro applies an 
average structure factor approximation, which rests on the assumption of homogeneous, 
monodisperse, spherical particles. As our samples consist of inhomogeneous, polydisperse, 
non-spherical particles, the use of an average structure approximation is inappropriate. 
Though structure factors for our samples could be calculated using polymer reference 
interaction site model (PRISM) theory, high-quality fits were obtained without the reliance 
on structure factors and they have hence been excluded from our calculations of I(q).[53, 54] 
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Supplementary information 
 
Supplementary Figure 1. Mass spectra for (a) Fmoc-DIKVAV and (b) Fmoc-FRGDF. 
 Supplementary Figure 2. Scattering data (blue) obtained using SAXS for  (a) DIKVAV, (b) 
FRGDF-DIKVAV mixed and  (c) co-assembled systems.  Various cylindrical models fitted 
to data are shown including cylinder (green), cylinder with polydisperse radius (purple), 
hollow cylinder (black), flexible cylinder (orange) and hollow cylinder with polydisperse 
radius (red). The hollow cylinder with polydisperse radius is the best fit for our SAXS data as 
highlighted at higher Q values for (d) DIKVAV, (e) FRGDF-DIKVAV mixed and  (f) co-
assembled systems.  
Supplementary Table 1. Chi-squared (χ2) values for the various form factor model fits to the 
experimental data for each SAP system. The optimal fit (bold) for each system is found with 
the hollow cylinder with polydisperse radius model.  
Form Factor Model FRGDF DIKVAV Mixed FRGDF-DIKVAV 
Co-Assembled 
FRGDF-DIKVAV 
Cylinder 26.23 7.55 11.19 28.89 
Cylinder (Polydisperse 
Radius) 12.38 1.72 4.63 8.64 
Hollow Cylinder 21.83 1.71 2.88 3.52 
Flexible Cylinder 12.11 3.28 4.99 17.40 
Hollow Cylinder 
(Polydisperse Radius) 4.40 1.62 1.88 1.02 
 
